Literature DB >> 15258227

Genetic heterogeneity in ten families with myoclonus-dystonia.

B Schüle1, N Kock, M Svetel, N Dragasevic, K Hedrich, P De Carvalho Aguiar, L Liu, K Kabakci, J Garrels, E-M Meyer, I Berisavac, E Schwinger, P L Kramer, L J Ozelius, C Klein, V Kostic.   

Abstract

BACKGROUND: Myoclonus-dystonia (M-D) is a movement disorder with autosomal dominant inheritance and reduced penetrance but may also occur sporadically. Recently, mutations in the epsilon-sarcoglycan gene (SGCE) were shown to cause M-D. Furthermore, single variants in the dopamine D2 receptor (DRD2) and DYT1 genes were found in combination with SGCE mutations in two M-D families, and another M-D locus was recently mapped to chromosome 18p11 in one family.
METHODS: The authors clinically and genetically characterised ten consecutive cases with myoclonus-dystonia; seven familial and three sporadic. Twenty nine M-D patients and 40 unaffected family members underwent a standardised clinical examination by a movement disorder specialist. Index cases were screened for mutations in the SGCE, DYT1, and DRD2 genes and for deletions of the SGCE gene. Suitable mutation negative families were tested for linkage to the SGCE region and to chromosome 18p11.
RESULTS: Two SGCE mutations were detected among the seven familial but no mutation in the sporadic cases. Haplotype analysis at the new M-D locus was compatible with linkage in two families and excluded in another family, suggesting at least one additional M-D gene. There were no obvious clinical differences between M-D families with and without detected mutations.
CONCLUSION: M-D is genetically heterogeneous with SGCE mutations accounting for the disease in only part of the clinically typical cases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15258227      PMCID: PMC1739169          DOI: 10.1136/jnnp.2003.027177

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  8 in total

1.  Network Analysis of Depression-Related Transcriptomic Profiles.

Authors:  Xiao Miao; Bin Fan; Rongqun Li; Shaoping Zhang; Honghuang Lin
Journal:  Neuromolecular Med       Date:  2019-03-01       Impact factor: 3.843

2.  Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes.

Authors:  S Tezenas du Montcel; F Clot; M Vidailhet; E Roze; P Damier; C P Jedynak; A Camuzat; A Lagueny; L Vercueil; D Doummar; L Guyant-Maréchal; J-L Houeto; G Ponsot; S Thobois; M-A Cournelle; A Durr; F Durif; B Echenne; D Hannequin; C Tranchant; A Brice
Journal:  J Med Genet       Date:  2005-10-14       Impact factor: 6.318

Review 3.  Genetic Aspects of Myoclonus-Dystonia Syndrome (MDS).

Authors:  Laila Rachad; Nadia El Kadmiri; Ilham Slassi; Hicham El Otmani; Sellama Nadifi
Journal:  Mol Neurobiol       Date:  2016-01-20       Impact factor: 5.590

4.  Reduced striatal D2 receptor binding in myoclonus-dystonia.

Authors:  R J Beukers; J Booij; N Weisscher; F Zijlstra; T A M J van Amelsvoort; M A J Tijssen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-22       Impact factor: 9.236

5.  Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency.

Authors:  Maria Stamelou; Niccolo E Mencacci; Carla Cordivari; Amit Batla; Nick W Wood; Henry Houlden; John Hardy; Kailash P Bhatia
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

6.  A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia.

Authors:  Niccolo E Mencacci; Ignacio Rubio-Agusti; Anselm Zdebik; Friedrich Asmus; Marthe H R Ludtmann; Mina Ryten; Vincent Plagnol; Ann-Kathrin Hauser; Sara Bandres-Ciga; Conceição Bettencourt; Paola Forabosco; Deborah Hughes; Marc M P Soutar; Kathryn Peall; Huw R Morris; Daniah Trabzuni; Mehmet Tekman; Horia C Stanescu; Robert Kleta; Miryam Carecchio; Giovanna Zorzi; Nardo Nardocci; Barbara Garavaglia; Ebba Lohmann; Anne Weissbach; Christine Klein; John Hardy; Alan M Pittman; Thomas Foltynie; Andrey Y Abramov; Thomas Gasser; Kailash P Bhatia; Nicholas W Wood
Journal:  Am J Hum Genet       Date:  2015-05-14       Impact factor: 11.025

7.  SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype.

Authors:  Kathryn J Peall; Manju A Kurian; Mark Wardle; Adrian J Waite; Tammy Hedderly; Jean-Pierre Lin; Martin Smith; Alan Whone; Hardev Pall; Cathy White; Andrew Lux; Philip E Jardine; Bryan Lynch; George Kirov; Sean O'Riordan; Michael Samuel; Timothy Lynch; Mary D King; Patrick F Chinnery; Thomas T Warner; Derek J Blake; Michael J Owen; Huw R Morris
Journal:  J Neurol       Date:  2014-09-11       Impact factor: 4.849

8.  Population Prevalence of Deleterious SGCE Variants.

Authors:  Mark S LeDoux
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-11-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.